Tuesday, October 20, 2026, 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Roche.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.
Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Keith J. Kaplan, MD, discusses his lab’s experience with the Sakura VisionTek Digital Microscope. At the Digital Pathology Blog, Dr. Kaplan calls the system “a must-see for real-time applications with point-to-point case sharing.” Read more.
In this HIStalk interview, Partners HealthCare pathology project director Lyman Garniss addresses the challenge laboratories face in managing genomic information, how EMR systems still fall short when compared with LIS, and the promise of biorepositories.
Viewics Inc., which makes software designed to help clinical and anatomic pathology laboratories with their dashboarding and data-mining needs, is offering a free demonstration on Thursday, Jan. 23. The demo aims to showcase how the company’s product can help track revenue and volume, analyze per-test costs and supply expenses, identify TAT outliers, and scrutinize workload, staffing, and QA/QC issues.Register.
Read how a patient risk approach to QC means planning your QC based on the type or method of the test and its impact on patient outcomes when a failure is detected.
Validating Whole Slide Imaging for Diagnostic Purposes in Pathology: This guideline, available in Archives of Pathology & Laboratory Medicine, marks a significant step in demonstrating the value of this emerging technology for diagnostic use.
Executives at Carmel, Ind.-based laboratory information system company Orchard Software share their views on how health care’s change from a volume-based to a value-based service model will affect the lab. This presentation points out specific ways that the laboratory can deliver for its facility and its customers in a value-based reimbursement world. Watch the video.
Digital Pathology Association Webinar, The use of digital pathology technology in research environment, features Robert W. Dunstan and Christopher D. Higgins.
GenMark offers on Tuesday, Sept. 17 for a free webinar on multiplex respiratory virus testing. As part of the webinar, Benjamin Pinsky, MD, PhD, Stanford University, will discuss the transition from traditional culture and direct antigen testing to molecular diagnostics. P.A.C.E. credit available. Register here.
AdvaMedDx’s free executive newsletter for August 2013 is now available. Covered in the newsletter is information about a diagnostics payment reform bill, FDA news on companion diagnostic tests, and views from the company’s director Andrew C. Fish. [Download here] * More CAP TODAY Recommends * *
As part of its ILuminations Webinar series, Instrumentation Laboratory will offer on Sept. 18 the free webinar, “Improving Clinical Outcomes in Critical Care.” Discussed in the webinar, which takes place from 11 a.m. to 12 p.m. EST, will be the hazards, benefits, and safe and effective practices in oxygen therapy. [Register here] * More CAP TODAY Recommends * *
